- Home
- OPTU vs PALI Comparison
OPTU vs PALI Comparison
Compare OPTU & PALI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | OPTU | PALI |
|---|---|---|
| Founded | 2015 | 1996 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Cable & Other Pay Television Services | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Telecommunications | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 411.9M | 359.0M |
| IPO Year | 2017 | 2019 |
Fundamental Metrics
Financial Performance| Metric | OPTU | PALI |
|---|---|---|
| Price | $0.98 | $1.46 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 13 | 8 |
| Target Price | $1.05 | ★ $10.22 |
| AVG Volume (30 Days) | 1.6M | ★ 3.4M |
| Earning Date | 11-05-2026 | 11-09-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 97.06 |
| EPS | N/A | ★ N/A |
| Revenue | ★ $8,590,467,000.00 | $260,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 1500.39 |
| 52 Week Low | $0.58 | $1.32 |
| 52 Week High | $2.14 | $2.86 |
Technical Indicators
Market Signals| Indicator | OPTU | PALI |
|---|---|---|
| Relative Strength Index (RSI) | 46.50 | 35.58 |
| Support Level | $0.91 | $1.32 |
| Resistance Level | $1.13 | $2.18 |
| Average True Range (ATR) | 0.08 | 0.10 |
| MACD | -0.01 | -0.00 |
| Stochastic Oscillator | 25.77 | 32.50 |
Price Performance
Historical ComparisonAbout OPTU Optimum Communications Inc. Class A common stock
Optimum's assets were brought together when Altice Europe acquired US cable companies Suddenlink in 2015 and Cablevision in 2016. The Suddenlink business, which management calls the "West," provides television, internet access, and phone services to roughly 4.5 million US homes and businesses located primarily in smaller markets, with major clusters in Texas, West Virginia, Idaho, Arizona, and Louisiana. The Cablevision portion, dubbed the "East," provides comparable services to about 5.5 million homes and businesses in the New York City metro area. Both regions now operate under the Optimum brand name. Altice Europe spun off Optimum, which includes both the Suddenlink and Cablevision operations, to shareholders in 2018.
About PALI Palisade Bio Inc.
Palisade Bio Inc is a clinical-stage biopharma company focused on identifying and developing therapeutics that protect the integrity of the intestinal barrier. Its portfolio consists of a PALI-2108 for the treatment of IBD, including UC and CD, and is researching PALI-1908.